KRSA
Korsana Biosciences, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$34.99
+3.77%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+45.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Pernice Michelle Patricia · director | A-Award | 48,445 | $26 |
| Sep 10, 2026 | Shah Nimish P · director | A-Award | 48,445 | $26 |
| Sep 10, 2026 | Fairmount Funds Management LLC · director, 10 percent owner: | A-Award | 48,445 | $26 |
| Sep 10, 2026 | Gottesdiener Andrew · director | A-Award | 48,445 | $26 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026